Teva Canada recalls some Pregabalin capsules over sertraline contamination concerns

Customers with items from affected lots advised to return products to pharmacies CBC News · Posted: Aug 16, 2026 PM EDT | Last Updated: 10 hours ago Play article Estimated 1 minute The audio version of this article is generated by AI-based technology. We are working with our partners to continually review and improve the results. The Teva-Pregabalin 150 mg capsules that are being recalled were first sold in Canada in September 2025 and have an expiration date of July 31, 2027. (Teva Canada) Teva Canada is recalling some of its Teva-Pregabalin 150 mg capsules after it said routine testing identified possible contamination with the drug sertraline. The two lots affected : 100070495 100068913 The items were first sold in Canada in September 2025 and have an expiration date of July 31, 2027. "Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure," according to a recall notice from Health Canada, noting anaphylactic reactions can be fatal. The agency said anyone with products from the above-mentioned lots should return them to a pharmacy as soon as possible. Pregabalin is a prescription drug used to treat pain caused . Sertraline is another prescription drug used to relieve symptoms of depression, obsessive-compulsive disorder and panic disorders. Toronto-based Teva Canada said in its recall notice on Friday that the move is a "precautionary measure." CBC's Journalistic Standards and Practices·About CBC News Corrections and clarifications·Submit a news tip·Report error